MFSD5 (Major Facilitator Superfamily Domain Containing 5) is a protein that belongs to the major facilitator superfamily (MFS), a diverse group of secondary transporters that facilitate the movement of a variety of substrates across cellular membranes. MFS proteins are ubiquitously found in all kingdoms of life and are characterized by their ability to transport small solutes in response to chemiosmotic ion gradients. These transporters play pivotal roles in numerous physiological processes, ranging from the uptake of nutrients to the efflux of waste products and xenobiotics. The MFS proteins typically possess 12 transmembrane domains and function by an alternating-access mechanism, where the transporter alternates between two conformational states to allow substrate binding and release on opposite sides of the membrane.
MFSD5 inhibitors represent a class of chemical compounds that specifically target and modulate the function or activity of the MFSD5 protein. The exact function of MFSD5 in human cells remains a subject of investigation, but given its membership in the MFS, it's plausible that it plays roles in solute transport across cellular membranes. Inhibitors of MFSD5 may act by blocking the substrate-binding site, altering the conformational dynamics of the protein, or interfering with its expression or stability. The study of MFSD5 inhibitors can shed light on the biological significance of this transporter, its substrate specificity, and its potential interactions with other cellular components. Furthermore, a deeper understanding of MFSD5's function and its modulation by specific inhibitors can contribute to a broader knowledge of the major facilitator superfamily's roles in cellular physiology and homeostasis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phloretin | 60-82-2 | sc-3548 sc-3548A | 200 mg 1 g | $63.00 $250.00 | 13 | |
Known to inhibit various MFS transporters, and could potentially affect MFSD5. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Influences various cellular pathways and may indirectly affect MFS transporter expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits protein synthesis in eukaryotic cells and could reduce MFSD5 expression. | ||||||
FCCP | 370-86-5 | sc-203578 sc-203578A | 10 mg 50 mg | $92.00 $348.00 | 46 | |
Uncouples oxidative phosphorylation, potentially impacting cellular energetics and MFS transporter expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Affects the mTOR pathway, which might indirectly influence MFSD5 expression. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Calcium channel blocker that might influence cellular processes affecting MFS transporter function. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Affects DNA methylation, potentially influencing the expression of various genes including MFSD5. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Inhibits RNA synthesis and could reduce MFSD5 mRNA levels. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
Inhibits glycolysis, potentially affecting cellular energetics and MFS transporter expression. | ||||||
Valinomycin | 2001-95-8 | sc-200991 | 25 mg | $163.00 | 3 | |
Can disrupt ion gradients, which might influence MFS transporter function. | ||||||